Liraglutide-induced injection site reaction
Liraglutide is an antidiabetic drug given subcutaneously for weight reduction. We report a 35-year-old woman who presented with a rash after starting liraglutide. The rash consisted of erythematous well-defined plaques surrounded by ecchymotic patches on extensor aspects of the thighs at the sites o...
Saved in:
Main Authors: | Nada Fouda Neel (Author), Yasser Ghobara (Author), Mohammed Turkmani (Author) |
---|---|
Format: | Book |
Published: |
Wolters Kluwer Medknow Publications,
2019-01-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Delayed type hypersensitivity injection site reaction and tolerance induction to liraglutide for the treatment of obesity
by: Martina Yaneva, MD, et al.
Published: (2023) -
Addition of cyclosporine to adalimumab improved psoriasis and adalimumab-induced injection site reaction
by: Satoshi Nakamizo, et al.
Published: (2014) -
Ulcerative injection-site reaction associated with dupilumab therapy
by: Michael Phan, BS, et al.
Published: (2020) -
Methotrexate injection site reactions: Case report and literature review
by: Japsimran Kaur, BS, et al.
Published: (2022) -
Injection site reactions after dupilumab or tralokinumab for atopic dermatitis
by: Fabrizio Martora, et al.
Published: (2024)